Oppenheimer Inc. (OPY)
NYSE: OPY
· Real-Time Price · USD
74.43
3.92 (5.56%)
At close: Sep 04, 2025, 3:59 PM
75.91
1.99%
Pre-market: Sep 05, 2025, 08:56 AM EDT
5.56% (1D)
| Bid | 70.36 |
| Market Cap | 775.63M |
| Revenue (ttm) | 1.49B |
| Net Income (ttm) | 87.57M |
| EPS (ttm) | 7.71 |
| PE Ratio (ttm) | 9.65 |
| Forward PE | 84.82 |
| Analyst | n/a |
| Ask | 85.5 |
| Volume | 65,058 |
| Avg. Volume (20D) | 56,358 |
| Open | 71.42 |
| Previous Close | 70.51 |
| Day's Range | 71.42 - 75.00 |
| 52-Week Range | 47.39 - 77.83 |
| Beta | 1.22 |
4 months ago
+0.9%
Shares of financial companies are trading higher a...
Unlock content with
Pro Subscription
4 months ago
+1.78%
Shares of financial companies are trading higher amid Treasury Secretary Scott Bessent's remarks about trade de-escalation with China, which may help restore investor confidence towards the sector.
1 month ago · https://thefly.com
Y-mAbs Therapeutics downgraded to Perform from Outperform at OppenheimerOppenheimer analyst Jeff Jones downgraded Y-mAbs Therapeutics without a price target to Perform from Outperform after the company agreed to be acquired by SERB Pharmaceuticals for $8.60 per share in c...
